Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Cyanoenamines as potassium channel modulators

Jan. 19, 1999

Warner-Lambert updates U.S. status of Rezulin

Jan. 18, 1999

Novel antidiabetic agents in development at Novo Nordisk

Jan. 18, 1999

More PDE5 inhibitors in the Pfizer pipeline

Jan. 18, 1999

Combination of lovastatin and acipimox for type II diabetes and mixed dyslipidemia

Jan. 15, 1999

Amantadine reverses adverse effects of neuroleptic drugs on sexual function in males

Jan. 15, 1999

Amylin files IND for antidiabetes drug and reports on feasibility of alternative delivery routes

Jan. 15, 1999

Amylin gears up for regulatory filing of pramlintide and presents new clinical data

Jan. 15, 1999

Novel compounds developed at Roche for lipid disorders and fungal infections

Jan. 15, 1999

Traditional Chinese medicine shows potential as Rx for hypercholesterolemia

Jan. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.